摘要
目的探讨有氧运动干预对心血管神经症(CN)的影响.方法将60例CN患者随机分为二组,即药物治疗组和运动治疗组各30例.药物治疗组给予谷维素和倍他乐克治疗,运动组在药物治疗基础上加用运动治疗,疗程3个月.两组治疗前均进行运动平板心电图检查,运动组根据测试结果的最大运动量的70%～80%制定运动量进行有氧运动.两组治疗前后采用症状自评量表(SCL-90)进行评分.结果 1.CN患者运动能力与正常人比较无统计学意义(最大心率161±10.1 vs 160.9±10.7,最大代谢当量10.4±2.1 vs 10.0±1.7,P均＞0.05);2.干预后运动组SCL-90各项评分明显低于药物治疗组(总分147.9±28.9 vs 186.0±43.7,总均分1.6±0.3 vs 2.1±0.5,阳性分91.8±42.7 vs 142.6±59.2,阳性均分2.6±0.4 vs 3.1±0.3,P均＜0.01),以躯体表现、抑郁、焦虑、恐怖尤为明显(分别为1.9±0.6 vs 2.2±0.6,1.8±0.6 vs 2.2±0.8,1.7±0.4 vs 2.6±0.8,1.4±0.3 vs 1.7±0.7,P均＜0.01).结论运动治疗心血管神经症安全、有效,值得临床推广.
ObjectiveTo explore the effect of aerobic exercise on patients with cardiovascular neurosis (CN). MethodsSixty patients with CN were randomly divided into an aerobic exercise group and a drug therapy group, each group has 30 patients. All the patients were treated with Oryzanol and Betaloc, while patients in aerobic exercise group also with exercise treatment. Each group was treated for three months. All the patients were examined by exercise treadmill. Those patients in aerobic exercise group did their exercise by 70%~80% of maximal exercise endurance according to the results of treadmill examination. The (SCL-90) scores were evaluated before and after treatment.Results1.There was no significant difference in exercise capability betweenpatients with CN and normal group(maxium heart rate 161±10.1 vs 160.9±10.7,maxium Mets 10.4±2.1 vs 10.0± 1.7 ,P>0.05 all).2. After treatment the scores of SCL-90 in aerobic exercise group were significant lower than that of drug therapy group(total score 147.9±28.9 vs 186.0±43.7,total average score 1.6±0.3 vs 2.1±0.5,positive score 91.8±42.7 vs 142.6±59.2,positive average score 2.6±0.4 vs 3.1±0.3, P<0.01 all),especially for symptoms、depression、anxiety and phobophobia (respectively 1.9±0.6 vs 2.2±0.6,1.8±0.6 vs 2.2±0.8,1.7±0.4 vs 2.6±0.8,1.4±0.3 vs 1.7±0.7,P<0.01 for all). ConclusionAerobic exercise therapy is a safe and effective treatment on patients with CN.
出处
《中国行为医学科学》
CSCD
2005年第5期421-422,424,共3页
Chinese Journal of Behavioral Medical Science
